Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regul...more...
The Exchange has sought clarification from BALAXI PHARMACEUTICALS LIMITED for the quarter ended 31-Mar-2026 with respect to Regulation 33 of...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publicationmore...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding RTA Report for Re-lodgement of Transfer Requests of Physical Shares for t...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publication.more...
The company reported standalone net profit during the quarter stood at Rs 0.16 crore compared to net loss of Rs 1.18 crore in the previous y...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Update on the Company s First Pharmaceuticals Formulation Plant at Jadcherla Hyder...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Re-appointment of Ms. Akshita Ostwal as Independent Director of the compa...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Re- appointment of M/s Siva Rama Krishna & Associates as Internal Auditor of the C...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Outcome of Board Meeting held on May 28 2026.more...
BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange the financial results for the period ended March 31 2026.more...
As of March 2026 65.99% is owned by Indian Promoters and 34.01% by Public. Top four Promoters holding highest number of shares of Balaxi Pha...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the period...more...
BALAXI PHARMACEUTICALS LIMITED has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Boar...more...
Ashish Maheshwari has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantia...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Significant movement in price has been observed in BALAXI PHARMACEUTICALS LIMITED. The Exchange in order to ensure that investors have latest relevan...more...
Significant movement in price has been observed in BALAXI PHARMACEUTICALS LIMITED. The Exchange in order to ensure that investors have lates...more...
BOARD MEETINGS Company Name : Supreme Infra. India Date : 04-07-2026